Summary & Overview
HCPCS G9793: Current Daily Aspirin or Other Antiplatelet
HCPCS Level II code G9793 denotes that a patient is currently taking daily aspirin or another antiplatelet agent. This documentation-focused code captures ongoing antiplatelet therapy status, which is clinically important for peri-procedural planning, cardiovascular risk management, and medication reconciliation across care settings. Nationally, standardized capture of antiplatelet use supports continuity of care and accurate clinical decision-making.
Key payers examined in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how the code is used across ambulatory and outpatient settings, typical service contexts, and commonly applied modifiers. The publication outlines benchmarks and common billing practices where available, summarizes clinical context related to antiplatelet therapy documentation, and flags areas where guidance or policy updates may affect use of the code.
This summary provides clinicians, billing professionals, and policy analysts with concise orientation to G9793, including the code’s purpose, the care settings where it is most relevant, and the payer landscape addressed in the full publication. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9793 indicates that the patient is currently on a daily aspirin or other antiplatelet. This code documents ongoing antiplatelet therapy as part of the patient's medication regimen.
Service Type: Medication documentation / Chronic medication management
Typical Site of Service: Outpatient clinic or ambulatory care setting, including primary care, cardiology, and other ambulatory specialty visits where medication history and antiplatelet therapy are reviewed.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult outpatient who is taking daily aspirin or another antiplatelet agent for secondary prevention of cardiovascular disease and who presents for an elective procedure, preoperative evaluation, or a surgical/endoscopic intervention. The clinical workflow includes medication reconciliation confirming current antiplatelet therapy, assessment of bleeding versus thrombotic risk, documentation of the antiplatelet agent, dose, and timing of last dose, and communication of this status in the pre-procedure note or operative report. The coding instance for G9793 is recorded when the patient is currently on daily aspirin or another antiplatelet; it is used by surgical, procedural, and preoperative teams (e.g., general surgery, cardiology, gastroenterology, anesthesia) to indicate ongoing antiplatelet therapy that may affect peri-procedural management and billing metadata. Examples: a 72-year-old with prior myocardial infarction on daily aspirin presenting for elective colonoscopy with polypectomy; a 65-year-old on clopidogrel after coronary stent presenting for elective hernia repair with pre-op anesthesia evaluation noting active antiplatelet therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the procedure due to complexity, prolonged time, or complications related to antiplatelet management. |